• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于检测耐碳青霉烯革兰氏阴性菌的灿烂 CRE 琼脂的评估

Evaluation of brilliance CRE agar for the detection of carbapenem-resistant gram-negative bacteria.

作者信息

Bracco Silvia, Migliavacca Roberta, Pini Beatrice, Corbo Nicoletta, Nucleo Elisabetta, Brigante Gioconda, Piazza Aurora, Micheletti Piero, Luzzaro Francesco

机构信息

Laboratory of Microbiology, A. Manzoni Hospital, Lecco, Italy.

出版信息

New Microbiol. 2013 Apr;36(2):181-6. Epub 2013 Mar 31.

PMID:23686124
Abstract

The aim of this work was to evaluate the performance of the new chromogenic medium BrillianceTM CREAgar (Thermo Fisher Scientific) for determining the limit of detection of carbapenem-resistant enterobacteria (CRE). A total of 70 clinical isolates were studied. Of these, 30 were well-characterized CRE, including Klebsiella pneumoniae strains producing KPC-, VIM-, and OXA-type enzymes, VIM-positive Enterobacter cloacae and Escherichia coli, NDM-positive E. coli, and enterobacterial isolates characterized by porin loss associated with ESBL production or AmpC hyperproduction. Ten carbapenem-resistant non-fermentative isolates were also included as well as 30 carbapenem-susceptible isolates. Carbapenem-resistant strains were inoculated at three different concentrations onto Brilliance CRE Agar (from 1.5x101 CFU/ml up to 1.5x104 CFU/ml) whereas carbapenem-susceptible isolates were inoculated at a concentration of 1.5x102 CFU/ml. The medium sustained the growth of carbapenem-resistant isolates, showing detection limits from 1.5x101 CFU/ml (in 31/40 cases) to 1.5x104 CFU/ml. No growth was observed with carbapenem-sensitive control strains. Our results indicate that the Brilliance CRE Agar allows the growth of carbapenem-resistant isolates with low detection limits and could represent a useful screening medium for both enterobacteria and non-fermentative Gram-negative strains resistant to carbapenems.

摘要

本研究旨在评估新型显色培养基BrillianceTM CRE琼脂(赛默飞世尔科技公司)对耐碳青霉烯类肠杆菌(CRE)检测限的性能。共研究了70株临床分离株。其中,30株为特征明确的CRE,包括产KPC型、VIM型和OXA型酶的肺炎克雷伯菌菌株、VIM阳性的阴沟肠杆菌和大肠埃希菌、NDM阳性的大肠埃希菌,以及以与超广谱β-内酰胺酶(ESBL)产生或AmpC高产生相关的孔蛋白缺失为特征的肠杆菌分离株。还包括10株耐碳青霉烯类非发酵菌分离株以及30株对碳青霉烯类敏感的分离株。将耐碳青霉烯类菌株以三种不同浓度接种到Brilliance CRE琼脂上(从1.5×101 CFU/ml到1.5×104 CFU/ml),而对碳青霉烯类敏感的分离株以1.5×102 CFU/ml的浓度接种。该培养基支持耐碳青霉烯类分离株的生长,检测限为1.5×101 CFU/ml(31/40例)至1.5×104 CFU/ml。对碳青霉烯类敏感的对照菌株未观察到生长。我们的结果表明,Brilliance CRE琼脂能够支持低检测限的耐碳青霉烯类分离株生长,对于肠杆菌和耐碳青霉烯类革兰氏阴性非发酵菌可能是一种有用的筛选培养基。

相似文献

1
Evaluation of brilliance CRE agar for the detection of carbapenem-resistant gram-negative bacteria.用于检测耐碳青霉烯革兰氏阴性菌的灿烂 CRE 琼脂的评估
New Microbiol. 2013 Apr;36(2):181-6. Epub 2013 Mar 31.
2
Characterization of carbapenem-resistant Gram-negative bacteria from Tamil Nadu.来自泰米尔纳德邦的耐碳青霉烯革兰氏阴性菌的特征分析。
J Chemother. 2016 Oct;28(5):371-4. doi: 10.1179/1973947815Y.0000000056. Epub 2016 Jul 22.
3
Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP).2009-10 年加拿大耐碳青霉烯类革兰氏阴性杆菌:加拿大医院感染监测计划(CNISP)的结果。
J Antimicrob Chemother. 2012 Jun;67(6):1359-67. doi: 10.1093/jac/dks046. Epub 2012 Mar 7.
4
Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya.肯尼亚目标革兰氏阴性菌碳青霉烯类不敏感临床分离株中多种碳青霉烯类和多重耐药基因及高危菌株类型的检测
PLoS One. 2021 Feb 22;16(2):e0246937. doi: 10.1371/journal.pone.0246937. eCollection 2021.
5
Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.黎巴嫩一家三级保健中心产超广谱β-内酰胺酶肺炎克雷伯菌和大肠埃希菌分离株碳青霉烯类耐药的潜在机制:OXA-48 和 NDM-1 碳青霉烯酶的作用。
Int J Antimicrob Agents. 2013 Jan;41(1):75-9. doi: 10.1016/j.ijantimicag.2012.08.010. Epub 2012 Nov 9.
6
Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory.临床实验室中对产碳青霉烯类敏感金属β-内酰胺酶革兰氏阴性杆菌的表型检测。
J Clin Microbiol. 2006 Sep;44(9):3139-44. doi: 10.1128/JCM.00879-06.
7
Emergence of carbapenemases in Gram-negative bacteria in Hamburg, Germany.德国汉堡革兰氏阴性菌中产碳青霉烯酶的出现。
Diagn Microbiol Infect Dis. 2011 Nov;71(3):312-5. doi: 10.1016/j.diagmicrobio.2011.07.011. Epub 2011 Sep 6.
8
In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.新型广谱肠外碳青霉烯类药物SM-216601的体外和体内抗菌活性
Antimicrob Agents Chemother. 2005 Oct;49(10):4185-96. doi: 10.1128/AAC.49.10.4185-4196.2005.
9
Pharmacodynamic profiling of doripenem, imipenem and meropenem against prevalent Gram-negative organisms in the Asia-Pacific region.多利培南、亚胺培南和美罗培南对亚太地区主要革兰氏阴性菌的药效学特征分析。
Int J Antimicrob Agents. 2013 Jan;41(1):47-51. doi: 10.1016/j.ijantimicag.2012.09.007. Epub 2012 Nov 3.
10
Laboratory evaluation of the CHROMagar KPC medium for identification of carbapenem-nonsusceptible Enterobacteriaceae.CHROMagar KPC 培养基对碳青霉烯类药物不敏感肠杆菌科的实验室评估。
Diagn Microbiol Infect Dis. 2011 Aug;70(4):565-7. doi: 10.1016/j.diagmicrobio.2010.03.005.

引用本文的文献

1
Performance Evaluation of BD Phoenix NMIC-413 Antimicrobial Susceptibility Testing Panel for Imipenem, Meropenem, and Ertapenem Against Clinical Carbapenem-Resistant and Carbapenem-Susceptible .BD Phoenix NMIC-413抗菌药物敏感性检测板对亚胺培南、美罗培南和厄他培南针对临床耐碳青霉烯类和碳青霉烯类敏感菌的性能评估
Front Med (Lausanne). 2021 Apr 14;8:643194. doi: 10.3389/fmed.2021.643194. eCollection 2021.
2
A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.分子诊断时代临床微生物学显色培养基的十年发展
Clin Microbiol Rev. 2017 Apr;30(2):449-479. doi: 10.1128/CMR.00097-16.
3
Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods.
产碳青霉烯酶生物体的肠道携带情况:监测方法的现状
Clin Microbiol Rev. 2016 Jan;29(1):1-27. doi: 10.1128/CMR.00108-14.